Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;21:432-438

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valentin, J. P.
Right arrow Articles by Humphreys, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valentin, J. P.
Right arrow Articles by Humphreys, M. H.

Hypertension, Vol 21, 432-438, Copyright © 1993 by American Heart Association


ARTICLES

Urodilatin binds to and activates renal receptors for atrial natriuretic peptide

JP Valentin, LA Sechi, C Qui, M Schambelan and MH Humphreys
Division of Nephrology, San Francisco General Hospital, CA 94110.

Urodilatin is a recently described member of the atrial natriuretic peptide family, thought possibly to be synthesized in the kidney. To determine if urodilatin binding sites are present in rat and human kidney, we evaluated the effect of urodilatin on iodine-125-labeled atrial natriuretic peptide (ANP) (100 pM) binding to tissue sections using an in situ autoradiographic technique. 125I-ANP binding occurred primarily in glomeruli and medullary structures of both rat and human kidney. Increasing concentrations of urodilatin yielded a monophasic displacement of 125I-ANP binding with an IC50 of 4.2 nM, a value nearly identical to that achieved with unlabeled ANP (7.2 nM). In additional experiments, rat glomeruli and inner medullary collecting duct cells were isolated and incubated in vitro with either ANP or urodilatin (10(- 11) to 10(-6) M) and cyclic guanosine-3',5'-monophosphate accumulation measured by radioimmunoassay. Dose-response curves for the two peptides were superimposable in each tissue; at 10(-6) M, ANP generated 613 +/- 41 and urodilatin 603 +/- 55 fmol cyclic guanosine monophosphate per 10 minutes per milligram protein in inner medullary collecting duct cells (p = NS). Thus, urodilatin is as effective as ANP in displacing 125I- ANP binding to both rat and human renal tissue and in generating cyclic guanosine monophosphate in renal target cells in the rat, suggesting that its physiological effects may occur through the same receptors and signaling pathways that mediate the actions of ANP.


This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Heringlake, K. Wagner, J. Schumacher, and H. Pagel
Urinary excretion of urodilatin is increased during pressure natriuresis in the isolated perfused rat kidney
Am J Physiol Renal Physiol, September 1, 1999; 277(3): F347 - F351.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. H. Bestle, N. V. Olsen, P. Christensen, B. V. Jensen, and P. Bie
Cardiovascular, endocrine, and renal effects of urodilatin in normal humans
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1999; 276(3): R684 - R695.
[Abstract] [Full Text] [PDF]